Product Information
OLANZAPINE 7.5 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.0944 per EA under NDC 43598016505. Its NADAC has been published 647 times since May 14, 2014.
FDA first approved this application on Apr 23, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598016505
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA076255FDA Approved
4/23/2012
TE Code
AB
On Market Since
12/10/2013
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE 7.5 MG TABLET has been published 647 times since May 14, 2014, and over the history we have for it it has declined 51.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0944 per EA |
|---|---|
| All-time high | $0.2347 (Dec 10, 2014) |
| All-time low | $0.0740 (Nov 20, 2024) |
| 52-week high | $0.0944 |
| 52-week low | $0.0862 |
| Median price | $0.1479 |
| Average price | $0.1455 |
| Largest weekly change | -31.7% (Nov 20, 2024) |
| Weeks tracked | 647 |
| Tracking since | May 14, 2014 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Olanzapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLANZAPINE 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE 7.5 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.0944 per EA (NDC 43598016505), effective Sep 30, 2026.
How has the price of OLANZAPINE 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OLANZAPINE 7.5 MG TABLET has declined 51.1%. It has been tracked across 647 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for OLANZAPINE 7.5 MG TABLET?
Since May 14, 2014, the NADAC for OLANZAPINE 7.5 MG TABLET has ranged from a low of $0.0740 (Nov 20, 2024) to a high of $0.2347 (Dec 10, 2014), with a median of $0.1479 per EA.
Are there cheaper alternatives to OLANZAPINE 7.5 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLANZAPINE 7.5 MG TABLET, is $0.0902 per EA — about 4% below OLANZAPINE 7.5 MG TABLET.
Who manufactures OLANZAPINE 7.5 MG TABLET?
OLANZAPINE 7.5 MG TABLET (NDC 43598016505) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.